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ABSTRACT 17 
In infected cells, the chromatin structure of the adenovirus genome DNA 18 
plays critical roles in its genome functions.  Previously, we have reported that in early 19 
phases of infection, incoming viral DNA is associated with both viral core protein VII 20 
and cellular histones.  Here we show that in late phases of infection, newly synthesized 21 
viral DNA is also associated with histones.  We also found that knockdown of CAF-1, 22 
a histone chaperone that functions in replication-coupled deposition of histones, does 23 
not affect the level of histone H3 bound on viral chromatin, although CAF-1 is 24 
accumulated at viral DNA replication foci together with PCNA.  Chromatin 25 
immunoprecipitation assays using epitope-tagged histone H3 demonstrated that histone 26 
variant H3.3, which is deposited onto the cellular genome in a replication-independent 27 
manner, is selectively associated with both incoming and newly synthesized viral DNAs.  28 
Microscopic analyses indicated that histones but not USF1, a transcription factor that 29 
regulates viral late gene expression, are excluded from viral DNA replication foci and 30 
this is achieved by oligomerization of DBP.  Taken together, these results suggest that 31 
the histone deposition onto newly synthesized viral DNA is most likely uncoupled with 32 
viral DNA replication, and a possible role of DBP oligomerization in this 33 
replication-uncoupled histone deposition is discussed.   34 
35 
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INTRODUCTION 36 
 In the cell nucleus, the genomic DNA is not naked, but forms chromatin 37 
structure with chromatin proteins.  The fundamental unit of the chromatin structure is a 38 
nucleosome, which consists of histone octamer (two copies each of histone H2A, H2B, 39 
H3, and H4) and DNA wrapping around the octamer.  Deposition of histones and/or 40 
remodeling of nucleosome arrays are critical processes for the expression of genome 41 
functions (2), since nucleosome packaging could be barrier for trans-acting factors to 42 
access their cognate sites on DNA.  Thus, the nucleosome structure must be strictly 43 
and dynamically regulated in connection with several events on chromatin, such as 44 
transcription, DNA replication, and DNA repair.   45 
Currently, it is known that histone deposition is carried out mainly by two 46 
fashions, DNA replication-dependent and independent ones, and a role of histone 47 
variants in these deposition pathways has been elucidated (14).  In mammalian somatic 48 
cells, there are three major histone H3 variants, H3.1, H3.2, and H3.3, and they have 49 
only slight differences in amino acid (aa) sequences (16).  The canonical histone H3, 50 
histone H3.1 and highly related variant H3.2 (which differs only 1 aa from H3.1) are 51 
expressed exclusively during S phase, while the expression of the variant H3.3 that 52 
differs 4 and 5 aa from H3.2 and H3.1, respectively, is observed throughout cell cycle.  53 
Thus, this variant is called “replication-independent” one (11).  Tagami et al. 54 
demonstrated that the canonical histone H3 (H3.1) interacts with histone chaperone 55 
CAF-1 complex and is deposited onto DNA in a replication-dependent manner, while 56 
HIRA specifically binds to and deposits histone variant H3.3 onto DNA independently 57 
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of DNA synthesis (43).  CAF-1 is composed of three subunits, p150, p60, and p48, and 58 
associated with the cellular DNA replication machinery through the interaction with 59 
PCNA, a sliding clamp for DNA polymerases, allowing DNA replication-coupled 60 
deposition of histones (40, 41, 50).  On the other hand, HIRA was identified as a DNA 61 
synthesis-independent histone chaperone by cell-free systems using Xenopus egg 62 
extracts (32), and histone variant H3.3 is shown to mark transcriptional active genomic 63 
regions (1).  Furthermore, additional H3.3-specific chaperones are recently identified.  64 
Daxx is one of components of PML nuclear bodies and reported to deposit histone H3.3 65 
onto the specific genomic regions such as telomeres and pericentric heterochromatin, 66 
together with an ATP-dependent chromatin remodeler, ATRX (10, 21).  It is also 67 
reported that in Drosophila cells, DEK is a coactivator of a nuclear receptor and 68 
functions as an H3.3-specific chaperone (37).  Thus, the mechanistic evidences for 69 
histone deposition are accumulating, in the case of cellular chromatin.   70 
 The regulatory events for chromatin structure are not limited to the cellular 71 
genome, as some viruses also have chromatin and/or chromatin-like structures with 72 
their own genomes.  The adenovirus (Ad) genome is a liner double-stranded DNA 73 
(dsDNA) of ~36000 bp in length.  In the virion, the Ad genome forms chromatin-like 74 
structure with viral basic core proteins, as it is revealed by electron microscopic 75 
analyses that viral core protein-DNA complexes purified from the virion show 76 
“beads-on-a-string” structure (49).  Among core proteins, protein VII is a major DNA 77 
binding protein that can introduce superhelical turns into DNA as do cellular histones 78 
(4), and remains associated with viral DNA after the entry of the nucleus (7, 17).  79 
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When viral DNA-core protein complexes purified from the virion are used as a template 80 
for cell-free DNA replication/transcription systems, the reactions occur at a much lower 81 
level, compared with the case of naked DNA, indicating that viral chromatin-like 82 
structure must be remodeled to execute its genome functions (22, 23).  Previously, we 83 
have identified host cell-derived remodeling factors for Ad chromatin with biochemical 84 
analyses (19, 22, 24, 26) and demonstrated that TAF-I, one of these host factors, plays 85 
an important role in the regulation of viral early gene expression in infected cells 86 
through the interaction with protein VII (15, 17, 18, 20, 27).  Thus, it is indicated that 87 
remodeling of Ad chromatin is a crucial process for its genome functions (13), as is the 88 
case for the cellular genome.  In addition, recently we have reported using chromatin 89 
immunoprecipitation (ChIP) assays that in early phases of infection, cellular histones 90 
are incorporated into viral DNA-protein VII complexes and histone modification occurs 91 
depending upon transcription states on viral chromatin, suggesting that cellular histones 92 
could be functional components of viral chromatin in infected cells (20).   93 
 As described above, although viral chromatin structure and its regulation in 94 
early phases of infection are being clarified, it is quite unclear how viral chromatin 95 
structure is regulated in late phases of infection.  In particular, since the expression of 96 
viral late genes is largely dependent on its own DNA replication (45), the regulation of 97 
the chromatin structure during viral DNA replication could be a key step.  Therefore, 98 
in this study we sought to elucidate the regulatory mechanism how the chromatin 99 
structure is formed on newly synthesized viral DNA through viral DNA replication, in 100 
particular with respect to the histone deposition.  We found that after the onset of viral 101 
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DNA replication, cellular histones are also incorporated into viral chromatin.  We also 102 
found that although CAF-1 is accumulated at the site of viral DNA replication, this 103 
factor seems not to be involved in the histone deposition during viral DNA replication, 104 
since knockdown of CAF-1 did not affect the binding level of histone H3 on viral 105 
chromatin and histone variant H3.3, which is deposited onto DNA in a DNA 106 
synthesis-independent manner, is specifically deposited onto viral DNA even after the 107 
onset of viral DNA replication.  Microscopic analyses suggest that histones but not 108 
USF1, a transcription factor which is shown to bind to and regulate transcription from 109 
viral major late promoter (MLP) (46), are excluded form the site of viral DNA 110 
replication, possibly by oligomerization of Ad single-stranded DNA (ssDNA) binding 111 
protein (DBP), one of viral DNA replication factors.  Based on these results, we would 112 
propose a model that unlike cellular chromatin, the histone deposition onto the newly 113 
synthesized viral DNA is not coupled with viral DNA replication.  A feasible role of 114 
this uncoupled deposition mechanism mediated by DBP oligomerization on Ad genome 115 
functions is discussed.   116 
117 
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MATERIALS AND METHODS 118 
Cells and viruses.   119 
 Maintenance of HeLa cells, and purification and infection of human 120 
adenovirus type 5 (HAdV5) were carried out essentially as described previously (18, 121 
20).  Hydroxyurea (HU) was added at the final concentration of 2 mM right after 122 
infection when DNA replication was to be blocked.  HeLa cells stably expressing 123 
EGFP-tagged histone H3.2 and H3.3 [a kind gift from Dr. M. Okuwaki (University of 124 
Tsukuba)] were also maintained as described above.  Transfection of expression 125 
plasmids was performed using GeneJuice (Novagen) according to the manufacturer’s 126 
protocol.   127 
 128 
Antibodies.   129 
 Antibodies used in this study are as follows: rabbit anti-histone H3 (catalog 130 
no. ab1791; abcam), rabbit anti-histone H4 (catalog no. 04-858; Millipore), rabbit 131 
anti-histone H2A (catalog no. ab18255; abcam), mouse anti-HIRA (catalog no. 04-1488; 132 
Millipore), mouse anti-FLAG M2 (catalog no. F3165; Sigma), rat anti-HA (3F10; 133 
Roche), and mouse anti-β-actin (Sigma) antibodies.  Rabbit anti-histone H2A-H2B, 134 
mouse anti-CAF-1 p150, and mouse anti-DBP antibodies were kindly provided by Dr. 135 
M. Okuwaki (University of Tsukuba), Dr. A. Verreault (University of Montreal), and Dr. 136 
W. C. Russel, respectively.  Rat anti-protein VII antibody was described elsewhere 137 
(17).   138 
 139 
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Vector construction.   140 
 To construct the expression vectors for USF1, full-length DBP, and its deletion 141 
mutant (DBPΔC, which lacks the C-terminal 17 aa), cDNA fragments of USF1, DBP, 142 
and DBPΔC were amplified by PCR, digested with BamHI and EcoRI, and cloned 143 
in-frame into pCHA vector containing a hemagglutinin (HA) epitope tag and the 144 
puromycin-resistance gene [pCHA-puro vector, kindly provided from K. Kajitani 145 
(University of Tsukuba)].  The resulting vectors are designated pCHA-puro-USF1, 146 
pCHA-puro-DBP, and pCHA-puro-DBPΔC, respectively.  Similarly, for the 147 
expression vector of PCNA, amplified cDNA fragment was digested with BamHI and 148 
cloned into pCHA-puro vector digested with BamHI and EcoRV (pCHA-puro-PCNA).  149 
The primers used here were as follows: 150 
5’-GTTTAGGATCCCATATGAAGGGGCAGCAG-3’ and 151 
5’-GGGCCGAATTCTTAGTTGCTGTCATTCTTG-3’ for USF1 cDNA, 152 
5’-AAAGGATCCATGGCCAGTCGGG-3' and 153 
5’-GCGGAATTCTTAAAAATCAAAGGGGTTCTG-3' for DBP cDNA, 154 
5’-AAAGGATCCATGGCCAGTCGGG-3' and 155 
5’-CCCGAATTCTTAGTTGCGATACTGG-3' for DBPΔC cDNA, and 156 
5’-AAAGGATCCATGTTCGAGGCGC-3' and 157 
5’-ATCGTCGACCTAAGATCCTTCTTC-3' for PCNA cDNA.   158 
 For preparation of cells stably expressing HA-PCNA, HeLa cells were transfected 159 
with pCHA-puro-PCNA and cultured in the presence of 2 μg/mL puromycin for 2 160 
weeks.   161 
 9
 For construction of the expression vector of histone H3.1, cDNA fragment of 162 
histone H3.1 was amplified by PCR, digested with NcoI, and cloned into pBS-FLAG 163 
vector (pBS-H3.1-FLAG).  Then, the DNA fragment containing cDNA of H3.1 and 164 
the C-terminal FLAG tag was obtained from pBS-H3.1-FLAG by digestion with 165 
BamHI and EcoRI, and cloned into pcDNA3 vector (pcDNA3-H3.1-FLAG).  The 166 
primers used here were as follows: 5’-AAAACCATGGCGCGTACTAAGCAG-3’ and 167 
5’-TTATTCCATGGCCGCCCTCTCCCCA-3’.   168 
 The expression vectors for FLAG-tagged histone H3.2 and H3.3 169 
(pcDNA3-H3.2-FLAG and pcDNA3-H3.3-FLAG) and HA-tagged DEK (pCHA-DEK) 170 
were generously provided by Dr. M. Okuwaki and Dr. S. Saito, respectively (University 171 
of Tsukuba).   172 
 173 
Indirect immunofluorescence assays.   174 
   Indirect immunofluorescence (IF) assays were carried out essentially as 175 
previously described (18).  Localization of the protein was visualized with the 176 
secondary antibodies (anti-mouse IgG conjugated with AlexaFluor 488, anti-mouse IgG 177 
conjugated with AlexaFluor 568, and anti-rabbit IgG conjugated with AlexaFluor 568; 178 
Invitrogen).  DNA was visualized by staining with TO-PRO-3 iodide (Invitrogen).  179 
Labeled cells were observed with confocal laser scanning microscopy (LSM5 Exciter; 180 
Carl Zeiss) using argon laser (488 nm) and He/Ne laser (546 and 633 mm) lines.   181 
 182 
ChIP, RT-PCR, siRNA-mediated knockdown, and western blot assays.   183 
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   These experiments were carried out essentially as described previously (20).  184 
siRNA targeted for CAF-1 p150 was commercially purchased (Stealth siRNA; 185 
Invitrogen).  Primers for CAF-1 p150 mRNA are as follows: 186 
5’-GGAGCAGGACAGTTGGAGTG-3’ and 5’-GACGAATGGCTGAGTACAGA-3’.  187 
Other primers for ChIP and RT-PCR assays were described elsewhere (20).  In all the 188 
experiments by quantitative PCR (qPCR), mean values with SD were obtained from 189 
three independent experiments.   190 
191 
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RESULTS 192 
Cellular histones are bound with viral chromatin both in early and late phases of 193 
infection.   194 
 Previously, we reported that in early phases of infection (before the onset of viral 195 
DNA replication), viral chromatin is composed of both viral core protein VII and 196 
cellular histones and this “chimeric” chromatin functions as template for transcription 197 
(20).  To examine whether histones are also bound with viral chromatin after the onset 198 
of viral DNA replication, we performed ChIP assays using antibodies against histones 199 
and protein VII (Fig. 1).  The viral DNA replication starts around 8 hpi (hours post 200 
infection) in our condition (17, 20).  In order to reveal the viral chromatin state 201 
during/right after viral DNA replication, HeLa cells infected at an MOI (multiplicity of 202 
infection) of 100 were harvested at 6 and 12 hpi for ChIP assays.  We chose five 203 
regions for ChIP assays, four viral genome regions (E1A pro, MLP, Hexon, E4 pro, Fig. 204 
1A) and one cellular genomic region (ribosomal RNA gene, rDNA) as a control (20).  205 
In this condition, the amount of viral DNA was increased by ~20 fold through viral 206 
DNA replication (Fig. 1B).  At 6 hpi, all core histones are bound with viral chromatin, 207 
but at the low binding level compared with cellular chromatin (Fig. 1C, histone H3, H4, 208 
and H2A-H2B).  This was in good agreement with our previous observation (20).  At 209 
12 hpi, core histones were also found to be associated with viral chromatin.  The 210 
binding level of histones on viral chromatin at 12 hpi was more than those at 6 hpi, but 211 
slightly less than those on cellular chromatin.  This is consistent with the previous 212 
report of electron microscopic analyses showing that viral genome DNA purified from 213 
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infected cells at late phases of infection has the nucleosome-like particles, which are 214 
less dense compared with cellular nucleosome arrays (3).  In contrast, the binding level 215 
of protein VII was drastically decreased after the onset of viral DNA replication (Fig. 216 
1C, protein VII), suggesting that newly synthesized viral DNA is mainly associated with 217 
cellular histones.  We do not exclude the possibility that protein VII remains associated 218 
with small population of viral chromatin because the binding level of protein VII on 219 
viral chromatin was still higher than that on cellular chromatin even at 12 hpi.  The 220 
ratio among core histones bound on viral chromatin was almost the same as that on 221 
cellular chromatin both at 6 (data not shown, 20) and 12 hpi (Fig. 1D), indicating that 222 
viral chromatin contains the canonical nucleosome structure.   223 
 224 
CAF-1 and PCNA are not involved in the histone deposition onto newly 225 
synthesized viral DNA.   226 
 It is known that during DNA replication of the cellular genome and some DNA 227 
virus genomes, histones are deposited by CAF-1, a replication-dependent histone 228 
chaperone (41, 43).  CAF-1 is associated with the DNA replication machinery through 229 
the interaction with PCNA, thereby enabling replication-coupled deposition of histone 230 
H3-H4 complexes (40).  Thus, it is worthwhile to examine whether CAF-1 and PCNA 231 
are also involved in the histone deposition onto newly synthesized Ad DNA, although 232 
there is no definitive evidence that those two are involved in the Ad DNA replication.  233 
To test this, we first performed IF assays using cells stably expressing HA-tagged 234 
PCNA (HA-PCNA) to examine the relationship among viral DNA replication, PCNA, 235 
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and CAF-1 (Fig. 2A).  Using antibody against DBP, Ad ssDNA binding protein 236 
involved in viral DNA replication, the place for viral DNA replication designated “viral 237 
DNA replication foci” (hereafter referred to as “VDRF”) can be visualized (31).  HeLa 238 
cells or cells stably HA-PCNA were infected at an MOI of 50, and at 18 hpi subjected to 239 
IF assays using anti-DBP and anti-HA antibodies.  In mock-infected cells, HA-PCNA 240 
was localized throughout the nucleus and shows the punctate localization in some cell 241 
population, as reported previously (29).  At 18 hpi, VDRF was observed as a 242 
donut-like signal using anti-DBP antibody, and we found that HA-PCNA showing 243 
punctate localization was accumulated inside VDRF.  We also observed the similar 244 
localization pattern of CAF-1 inside VDRF (see below in Fig. 4A).  These results 245 
suggest that PCNA and CAF-1 are recruited together into the site of viral DNA 246 
replication.   247 
 Next, to investigate a role of CAF-1 in the histone deposition onto viral DNA, 248 
siRNA-mediated knockdown of CAF-1 p150, a largest subunit of CAF-1 complex, was 249 
carried out (Fig. 2B, C, and D).  HeLa cells were treated with control siRNA (siCont) 250 
or siRNA for CAF-1 p150 (siCAF-1), infected with HAdV5 at an MOI of 100, and 251 
harvested at 6 and 12 hpi.  First, we examined the knockdown efficiency of CAF-1 252 
p150 by RT-qPCR assays (Fig. 2B).  The mRNA level of CAF-1 p150 in 253 
siRNA-treated cells was about 20% of those in control cells, although at 12 hpi the level 254 
was slightly increased possibly due to S-phase like environment induced by Ad 255 
infection (30).  In contrast, the mRNA level of GAPDH was almost unaffected by 256 
siRNA treatment and Ad infection.  In this condition, the binding level of histone H3 257 
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on viral chromatin was examined by ChIP assays (Fig. 2C).  The binding level of H3 258 
on viral chromatin was not decreased by CAF-1 knockdown, and rather slightly 259 
increased (but not statistically significant) at 12 hpi (Fig. 2C, E1A pro and MLP).  It is 260 
noted that the binding level of H3 on cellular chromatin was also unaffected by CAF-1 261 
knockdown (Fig. 2C, rDNA, see Discussion).  In addition, we could not observe any 262 
effect of CAF-1 knockdown on viral DNA replication levels (Fig. 2D).  Taken together, 263 
these results suggest that it is not likely that CAF-1 is involved in the histone deposition 264 
onto viral chromatin during viral DNA replication, although CAF-1 is accumulated at 265 
VDRF together with PCNA.   266 
 267 
Replication-independent histone H3.3 is selectively incorporated into viral 268 
chromatin.   269 
 It is known that among histone H3 variants, histone H3.1 and H3.2 are 270 
deposited onto DNA by CAF-1 during DNA replication, while H3.3 is deposited 271 
independently of DNA replication (11, 14).  If CAF-1 is not involved in the histone 272 
depostion during viral DNA replication, histone H3.3 rather than H3.1 and H3.2 could 273 
be incorporated into newly synthesized viral DNA.  Therefore, to examine this 274 
possibility, we performed ChIP assays using FLAG-tagged histone H3.2 and H3.3 (Fig. 275 
3).  HeLa cells were transfected with expression vectors for H3.2 and H3.3 and at 24 276 
hpt (hours post transfection) infected at an MOI of 100.  We first studied using cells at 277 
early phases of infection (before the onset of viral DNA replication) (Fig. 3A).  278 
Infected cells were harvested at 2 and 6 hpi, and at 10 hpi in presence of HU to block 279 
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viral DNA replication (20), and subjected to ChIP assays with anti-FLAG antibody.  280 
As shown in Figure 3A, the exclusive binding of H3.3 on viral chromatin was observed 281 
at all the regions we tested, with a gradual increment as infection proceeded.  This is 282 
consistent with the recent report on helper-dependent Ad vector (HdAd) indicating that 283 
histone H3.3 are specifically deposited onto HdAd DNA by HIRA, an H3.3-specific 284 
histone chaperone (34).  Since HdAd alone does not undergo its DNA replication, the 285 
chromatin state of HdAd may reflect that of wildtype Ad in early phases of infection (13, 286 
34).   287 
Next we performed ChIP assays at 12 hpi to examine which H3 variant is 288 
deposited onto newly synthesized viral DNA (Fig. 3B).  We found that histone H3.3 289 
but not H3.2 was associated with viral chromatin at this time point, as observed in early 290 
phases of infection.  The expression levels of both H3 variants were comparable (Fig. 291 
3C), and both variants were associated with cellular chromatin with a similar binding 292 
level (Fig. 3A and B, rDNA).  These strongly suggest that this result was not due to 293 
some technical issues.  Further, we obtained the same results by using FLAG-tagged 294 
histone H3.1 instead of H3.2 (Fig. 3D and E).  Thus, these results suggest that 295 
replication-independent histone variant H3.3 is selectively deposited onto not only 296 
incoming but also newly synthesized viral DNA in infected cells.   297 
 298 
Histones but not transcription factor USF1 are excluded from the site of viral DNA 299 
replication.   300 
 To further investigate the histone fluctuation during viral DNA replication, we 301 
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performed IF analyses using HeLa cells stably expressing EGFP-tagged histone H3.3 302 
(Fig. 4A).  Cells were infected at an MOI of 50, and at 18 hpi subjected to IF assays 303 
using anti-DBP antibody (Fig. 4A, upper panels).  VDRF was observed at 18 hpi as 304 
described above, and H3.3-EGFP was found to be excluded from VDRF.  Similar 305 
results were obtained by using cells stably expressing EGFP-tagged histone H3.2 (Fig. 306 
4B).  This was due to neither exogenous expression nor EGFP tag of H3 variants as we 307 
observed the similar exclusion of the endogenous histone using anti-histone H2A 308 
antibody (Fig. 4C).  This localization pattern was specific for late phases of infection 309 
since the localization of EGFP-tagged H3 variants was not changed in early phases of 310 
infection (Fig. 4D).  We also performed IF analyses using anti-CAF-1 p150 antibody 311 
and observed that CAF-1 was accumulated at “histone-less” region, that is, VDRF (Fig. 312 
4A, lower panels), as was observed with HA-PCNA (Fig. 2A).  In summary, these 313 
results indicated that histones are localized reciprocally to VDRF (and CAF-1/PCNA) 314 
in late phases of infection.   315 
 To gain more insights into the accessibility of other nuclear proteins to VDRF, 316 
we again performed IF analyses (Fig. 5).  First, IF analyses were carried out using 317 
antibody against HIRA, an H3.3-specific histone chaperone, and it was observed that 318 
the localization of HIRA was not drastically changed in both early and late phases of 319 
infection (Fig. 5A).  We also performed IF analyses using cells transiently transfected 320 
with expression vectors for HA-tagged DEK and USF1 (Fig. 5B and C).  DEK is a 321 
cellular chromatin protein with potential histone chaperone activity (37), and USF1 is 322 
an E-box-binding transcription factor and reported to bind to and regulate transcription 323 
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from the MLP region (46).  HeLa cells were transfected with expression vectors and at 324 
24 hpt subjected to western blot analyses (Fig. 5B) or infected at an MOI of 50.  At 18 325 
hpi, localization of DBP, HA-DEK, and HA-USF1 was visualized by IF analyses using 326 
anti-DBP and anti-HA antibodies (Fig. 5C).  In mock-infected cells, both HA-tagged 327 
proteins showed nuclear localization, and in the case of HA-DEK, a strong signal was 328 
observed at the nuclear periphery.  At 18 hpi, HA-DEK appeared to be excluded from 329 
VDRF (Fig. 5C, HA-DEK).  However, in contrast to HA-DEK, we observed that 330 
HA-USF1 could be localized inside VDRF (Fig. 5C, HA-USF1).  Taken together, our 331 
IF analyses suggest that VDRF may allow selective access of cellular nuclear proteins, 332 
and at least one of transcription factors, USF1, is able to access the inside of VDRF.   333 
 334 
Oligomerization of DBP is critical for the histone exclusion from VDRF.   335 
 To investigate the mechanism of the histone exclusion from VDRF, we 336 
hypothesized that DBP may play a role, since an abundant amount of DBP is associated 337 
with Ad DNA in VDRF.  The crystal structure of DBP revealed that this protein has a 338 
17 aa extension at its C-terminus (see Fig. 6A), and this C-terminal “arm” hooks onto 339 
the next DBP molucule, resulting in oligomerization of DBP (47).  It was also reported 340 
that oligomerization of DBP mediated by the C-terminal “arm” enables 341 
ATP-independent unwinding of dsDNA, and thus full-length DBP, but not the deletion 342 
mutant that lacks the C-terminal “arm” (DBPΔC), could support viral DNA replication 343 
in vitro (9).  Therefore, to examine a role of DBP and its oligomerization on the 344 
histone localization, HeLa cells expressing histone H3.3-EGFP were transfected with 345 
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the expression vectors for HA-tagged full-length DBP or DBPΔC and at 36 hpt 346 
subjected to western blotting and IF assays using anti-HA and anti-DBP antibodies (Fig. 347 
6B and C).  The expression levels of both DBP proteins were almost the same as 348 
indicated by western blotting (Fig. 6B).  In IF analyses, we observed that full-length 349 
DBP forms the foci like VDRF in the absence of any viral proteins/DNA, and histone 350 
H3.3-EGFP was excluded from these foci as observed in infected cells (Fig. 6C, 351 
HA-DBP).  In sharp contrast, DBPΔC was localized throughout the nucleus and did 352 
not form such foci (Fig. 6C, HA-DBPΔC).  Taken together, these results suggest that 353 
the oligomerization of DBP has a critical role in the histone exclusion from VDRF.   354 
 355 
356 
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DISCUSSION 357 
 In this study we showed that replication-independent histone variant H3.3 is 358 
deposited onto both incoming and newly synthesized Ad DNA (Fig. 3).  These results, 359 
together with the results from knockdown experiments of CAF-1 (Fig. 2) and 360 
microscopic analyses (Figs. 4, 5, and 6), indicated that the histone deposition onto the 361 
replicated virus genome is most likely uncoupled with viral DNA replication.  Based 362 
on these results, together with the previous our work (20), we hypothesize a model with 363 
respect to the fluctuation of viral chromatin structure during infection cycle (Fig. 7).  364 
In virions, viral DNA is tightly packed with viral core proteins (13).  After the entry to 365 
the cell, cellular histones are incorporated into incoming viral DNA-protein VII 366 
complexes in the nucleus, and viral chromatin composed of both protein VII and 367 
histones functions as template for viral early gene expression (20).  In this process, 368 
histone H3.3 is specifically deposited onto viral DNA, possibly by a histone chaperone 369 
HIRA (34).  As infection proceeds and then viral DNA replication is initiated, 370 
oligomerization of DBP establishes the “histone-free” environment for viral DNA 371 
replication.  Newly synthesized viral DNA is then associated with histone H3.3 in a 372 
replication-uncoupling fashion and might be acting as template for viral late gene 373 
expression outside VDRF (31).  In later phases of infection (24~ hpi), both histones 374 
and newly synthesized core proteins VII and V are associated with viral DNA, which 375 
likely reflects the processes during the progeny virion assembly (35).  Since histones 376 
are not included in virions, histones must be removed and replaced with newly 377 
synthesized core proteins for progeny virions.  Although the packaging mechanism of 378 
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progeny viral DNA during virion assembly remains unclear, we have reported the 379 
involvement of a nucleolar protein B23/nucleophosmin in the regulation of viral 380 
chromatin structure during progeny virion assembly (35, 36).   381 
 The mechanistic details of the histone deposition after viral DNA replication 382 
remain still unclear.  First, what factor(s) is involved in the histone deposition at late 383 
phases of infection?  HIRA is a potential candidate for this process, likewise in early 384 
phases of infection (34).  However, we did not perform knockdown experiments for 385 
HIRA, since even if we could observe some effect of HIRA knockdown on viral 386 
chromatin in late phases of infection, we could hardly distinguish whether the 387 
knockdown directly affects the chromatin structure of progeny viral DNA or the effect 388 
is derived indirectly from earlier events on incoming viral chromatin.  IF analyses 389 
showed that the localization of HIRA was not drastically changed during infection cycle 390 
(Fig. 5A).  Recent reports indicated that Daxx, a component of PML bodies, is also an 391 
H3.3-specific histone chaperone (10, 21).  However, Daxx seems not to function the 392 
H3.3 deposition onto viral DNA because during Ad infection, some components of PML 393 
bodies including Daxx are re-localized by viral protein E4orf3, possibly for inactivation 394 
of the components (6, 42).  Indeed, it is shown that Daxx-mediated antiviral response 395 
is antagonized by E4orf3 (48).  It is also revealed that Daxx negatively functions and 396 
undergoes E1B-55K- and proteasome-dependent degradation during Ad infection (39).  397 
Furthermore, most recently Schreiner et al. reported that during/immediately after 398 
nuclear import of incoming virus genome, protein VI, one of capsid proteins, binds to 399 
and counteracts Daxx, at least partly by displacing it from PML bodies (38).  These 400 
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reports strongly suggest that Daxx is inactivated entirely throughout infection cycle by 401 
viral proteins.  DEK is also recently reported as a chaperone for histone H3.3 in 402 
Drosophila cells (37), but it is unknown whether human DEK also functions as a 403 
variant-specific chaperone or not.  Our IF analyses indicated that exogenously 404 
expressed DEK is excluded from VDRF (Fig. 5B and C).  Further studies are needed 405 
to elucidate the functions of these factors in late phases of infection.   406 
In this study, we could not observe a role of CAF-1 in the histone deposition 407 
onto viral DNA, while the accumulation of CAF-1 at VDRF was observed (Figs. 2 and 408 
4A).  CAF-1 knockdown did not affect the binding levels of histone H3 on viral 409 
chromatin (Fig. 2C).  Although we could not exclude the possibility that the 410 
knockdown efficiency of CAF-1 is not sufficient in the condition employed here, we 411 
concluded that the function of CAF-1 is largely inhibited under our condition:  We 412 
observed that siCAF-1-treated cells exhibit aberrant cell shapes (data not show) and the 413 
knockdown affects viral gene expression (see below).  Second, histone H3.3 is 414 
selectively incorporated into viral chromatin (Fig. 3), while CAF-1 generally functions 415 
as a chaperone for H3.1 and H3.2 (43).  Third, although CAF-1 is reported to be able 416 
to be associated with H3.3 under some specific conditions (10, 21), we could not 417 
observe any interaction between CAF-1 and H3.3 during Ad infection, at least, in our 418 
experimental conditions (data not shown).  In addition to their roles during DNA 419 
replication, CAF-1 and PCNA are also reported to be involved in the DNA damage 420 
response pathway (29).  Carson et al. reported that the DNA damage response pathway 421 
is only partially activated during Ad infection, and some related factors, such as ATRIP 422 
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and TopBP1, are accumulated at VDRF (5).  Therefore, CAF-1 (and PCNA) might 423 
localize at VDRF in the course of this limited DNA damage response.  Recently, it was 424 
reported that FACD2, one of factors involved in the DNA damage response, is 425 
accumulated at VDRF, and loss of this protein results in less expression of viral late, but 426 
not early, genes (8).  Similarly, we observed that CAF-1 knockdown affects mRNA 427 
levels of viral late genes without any effect on viral DNA replication (unpublished 428 
observation).  Thus, factors related to the DNA damage response such as FANCD2 and 429 
CAF-1 might be required for viral late gene expression, although the underlying 430 
mechanisms are unknown.  In our condition, CAF-1 knockdown did not affect the 431 
binding level of histone H3 on cellular chromatin (Fig. 2C, rDNA).  This is consistent 432 
with the report that loss of CAF-1 impairs replication-coupled deposition of histones but 433 
the formation of nucleosome arrays on genomic DNA is still observed in the absence of 434 
CAF-1 (44).  In addition, a recent report demonstrated that a defect of histone H3.1 435 
deposition by CAF-1 depletion could be rescued by HIRA-mediated H3.3 deposition 436 
(33).  Thus, in the case of cellular chromatin, alternative histone deposition pathway(s) 437 
could rescue the loss of CAF-1 function.   438 
 It remains to be clarified what is the biological/virological significance of 439 
histone deposition uncoupled with viral DNA replication.  On cellular chromatin, a 440 
replication-dependent histone chaperone CAF-1 is associated with the DNA replication 441 
machinery and deposits histone H3.1-H4 (and H3.2-H4) complexes during DNA 442 
replication (14, 40, 43).  This DNA replication-coupled system of the histone 443 
deposition is thought to be also utilized by some DNA viruses.  For instance, DNA 444 
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replication of SV40 is largely depending on the cellular replication machinery, and 445 
indeed CAF-1 was originally identified using cell-free DNA replication systems of 446 
SV40 (41).  In cytomegalovirus infection, it is reported that cellular histones, CAF-1, 447 
and PCNA are accumulated at viral replication compartments (25).  In the case of 448 
herpes simplex virus type 1, it is shown that histone H3.3 is first deposited onto 449 
incoming viral DNA by HIRA, and then H3.1 becomes associated with viral DNA 450 
accompanied with viral DNA replication (28).  It is suggested that this functional link 451 
between DNA replication and the histone deposition enables to transfer “epigenetic 452 
memory” such as histone modifications to the daughter DNA strands (43).  Thus, some 453 
DNA viruses might take advantage of this system for late gene expression, which 454 
generally occurs after viral DNA replication.  On the other hand, Ad seems to utilize 455 
another strategy, that is, the uncoupling mechanism, as shown here.  Like other DNA 456 
viruses, Ad late genes are expressed only after the onset of viral DNA replication.  457 
Thomas and Mathews demonstrated that Ad late gene expression requires its DNA 458 
replication in cis (45), although the molecular mechanism remains to be determined.  459 
This report leads us to hypothesize that the regulation of viral chromatin structure 460 
during DNA replication could be an important process for the late gene expression.  In 461 
general, histone/nucleosome structure on DNA restricts the access of trans-acting 462 
factors, such as transciption factors.  In this view, DBP is an attractive candidate of the 463 
key regulatory factor for DNA replication-dependent expression of viral late genes.  464 
By oligomerization, DBP is able to not only support viral DNA replication, but also 465 
establish the “histone-free” environment, which could be an opportunity window for 466 
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transcription factors to access the viral DNA for the activation of viral late genes.  Our 467 
IF analyses showed that transcription factor USF1, which binds to the MLP region after 468 
viral DNA replication (46), are not excluded from VDRF (Fig. 5B and C), supporting 469 
this notion.  Further, this is in agreement with the report that DBP enhances the 470 
binding of USF1 to the MLP region in vitro (51).  Overall, we speculate that 471 
uncoupling of the histone deposition with viral DNA replication is mediated by DBP 472 
oligomerization, at least partly, and plays a role in DNA replication-dependent 473 
activation of viral late gene expression.   474 
 The expression of certain cellular genes, such as HoxB gene, is shown to 475 
require DNA replication (12).  However, the regulation mechanism of “DNA 476 
replication-dependent gene expression” remains to be determined.  As Ad has late 477 
genes, the expression of which are DNA replication-dependent (45), this virus could be 478 
a good model for the analyses of such regulations.  Therefore, this study might give a 479 
clue for understanding the functional relationship between DNA replication and 480 
transcription on cellular and/or viral chromatin.   481 
482 
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FIGURE LEGENDS 656 
FIG. 1.  Viral chromatin structure in early and late phases of infection.  (A)  657 
The structure of Ad genome.  Arrows represent promoters of viral genes.  Target 658 
regions for ChIP assays are indicated by arrowheads.  (B)  The amounts of viral DNA.  659 
HeLa cells were infected with HAdV5 at an MOI of 100, and DNA samples were 660 
purified from infected cells at 6 and 12 hpi.  The amount of viral DNA was 661 
quantitatively measured by qPCR using primers for the E1A promoter region.  The 662 
amount of viral DNA was graphed as the ratio relative to that at 6 hpi.  (C)  ChIP 663 
assays.  HeLa cells were infected with HAdV5 at an MOI of 100 and subjected to 664 
ChIP assays using infected cells at 6 and 12 hpi.  Immunoprecipitation was carried out 665 
using indicated antibodies and anti-FLAG antibody (as a negative control).  The 666 
obtained DNAs were quantitatively measured by qPCR using indicated primer sets.  667 
The binding levels of each protein were calculated as relative enrichment against that 668 
obtained in a negative control (anti-FLAG antibody).  (D)  The binding levels of core 669 
histones.  Base on the results of ChIP assays shown in (C), the binding level of histone 670 
H4 and H2A-H2B was normalized by that of histone H3. 671 
 672 
FIG. 2.  Localization and role of PCNA and CAF-1 during viral DNA replication.  673 
(A)  IF assays.  HeLa cells and cells stably expressing HA-PCNA grown on cover 674 
slips were mock-infected or infected with HAdV5 at an MOI of 50.  At 18 hpi the 675 
localization patterns of HA-PCNA and DBP were analyzed by IF using anti-HA and 676 
anti-DBP antibodies.  DNA was visualized by TO-PRO-3 iodide staining.  Merged 677 
 33
images are also indicated.  Higher-magnified images of the regions marked by squares 678 
are shown below.  (B)  RT-qPCR assays.  HeLa cells were treated with siControl or 679 
siCAF-1 and then either mock-infected or infected with HAdV5 at an MOI of 100, and 680 
total RNAs were purified at 6 and 12 hpi.  cDNAs were synthesized with reverse 681 
transcription and subjected to qPCR using primer sets for CAF-1 p150 and GAPDH 682 
mRNAs.  The mRNA levels relative to those in control cells at 12 hpi were graphed.  683 
(C)  ChIP assays.  siRNA-treated cells were infected with HAdV5 at an MOI of 100 684 
and at 6 and 12 hpi subjected to ChIP assays using anti-histone H3 and anti-FLAG 685 
antibodies as described above.  (D)  Relative amounts of viral DNA.  Viral DNA 686 
was purified from lysates for ChIP assays in (C) and subjected to qPCR using primer set 687 
for the E1A promoter.  The DNA amounts at 12 hpi relative to those at 6 hpi were 688 
shown.   689 
 690 
FIG. 3.  Incorporation of histone H3 variants into viral chromatin.  (A, B)  ChIP 691 
assays with FLAG-tagged histone H3 variants.  HeLa cells were transfected with 692 
pcDNA3 empty vector, pcDNA3-H3.2-FLAG, or pcDNA3-H3.3-FLAG, and at 24 hpt 693 
(hours post transfection) infected with HAdV5 at an MOI of 100.  At 2, 6, and 10 hpi 694 
(A) or 12 hpi (B), ChIP assays were carried out using anti-FLAG and anti-HA (as a 695 
negative control) antibodies, as described above.  Note that in the case of 10 hpi, HU 696 
was added to block viral DNA replication.  The results were graphed as relative 697 
enrichment as described above.  (C)  Western blot analyses.  At 24 hpt, lysates were 698 
prepared from cells transfected with pcDNA3 empty (lane 1), pcDNA3-H3.2-FLAG 699 
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(lane 2), and pcDNA3-H3.3-FLAG (lane 3) and subjected to 15% SDS-PAGE, followed 700 
by western blot analyses using anti-FLAG (upper panel) and anti-β-actin (lower panel) 701 
antibodies.  (D)  Western blot analyses.  HeLa cells were transfected with pcDNA3 702 
empty vector (lane 1), pcDNA3-H3.1-FLAG (Lane 2), or pcDNA3-H3.3-FLAG (lane 3), 703 
and at 24 hpt lysates were prepared and subjected to 15% SDS-PAGE, followed by 704 
western blot analyses using anti-FLAG (upper panel) and anti-β-actin (lower panel) 705 
antibodies.  (E)  ChIP assays.  HeLa cells transfected with pcDNA3 empty vector 706 
(lanes 2, 3, 9, and 10), pcDNA3-H3.1-FLAG (lanes 4, 5, 11, and 12), or 707 
pcDNA3-H3.3-FLAG (lanes 6, 7, 13, and 14) were infected with HAdV5 at an MOI of 708 
100.  At 10 hpi (left panels, lanes 1-7) or 12 hpi (right panels, lanes 8-14), ChIP assays 709 
were carried out using anti-FLAG (lanes 3, 5, 7, 10, 12, and 14) and anti-HA (as a 710 
negative control, lanes 2, 4, 6, 9, 11, and 13) antibodies.  In the case of 10 hpi, HU was 711 
added to block viral DNA replication.  The immunoprecipitated DNAs were amplified 712 
by semi-quantitative PCR using the indicated primer sets.  PCR products were 713 
separated on a 7% polyacrylamide gel and visualized by staining with EtBr.  Input 714 
DNAs (lanes 1 and 8) were purified from 0.5% of lysates of cells transfected with the 715 
empty vector.   716 
 717 
FIG. 4.  Localization of histones in late phases of infection.  (A)  IF analyses 718 
using cells stably expressing histone H3.3-EGFP.  HeLa cells stably expressing histone 719 
H3.3-EGFP grown on cover slips were mock-infected or infected at an MOI of 50, and 720 
at 18 hpi subjected to IF assays using anti-DBP (upper panels) and anti-CAF-1 p150 721 
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(lower panels) antibodies, as described above.  Higher-magnified images of the regions 722 
marked by squares are shown below.  (B)  Localization of histone H3.2 in late phases 723 
of infection.  HeLa cells stably expressing histone H3.2-EGFP were mock-infected or 724 
infected with HAdV5 at an MOI of 50, and at 18 hpi subjected to IF analyses using 725 
anti-DBP antibody.  Higher-magnified images of the regions marked by squares are 726 
shown.  (C)  Localization of endogenous histone H2A in late phases of infection.  727 
HeLa cells were mock-infected or infected with HAdV5 at an MOI of 50, and at 18 hpi 728 
subjected to IF assays using anti-histone H2A and anti-DBP antibodies.  729 
Higher-magnified images of the regions marked by squares are shown below.  (D)  730 
Histone localization in early phases of infection.  HeLa cells stably expressing histone 731 
H3.2-EGFP and H3.3-EGFP were mock-infected or infected with HAdV5 at an MOI of 732 
250, and at 4 hpi subjected to IF analyses using anti-protein VII antibody.   733 
 734 
FIG. 5.  Localization of nuclear proteins in late phases of infection.  (A)  IF 735 
analyses using anti-HIRA antibody.  HeLa cells were mock-infected or infected with 736 
HAdV5 at an MOI of 250 (for 4 hpi) or 50 (for 18 hpi) and subjected to IF analyses 737 
using anti-protein VII and anti-HIRA antibodies.  (B)  Western blot analyses.  738 
Lysates were prepared from HeLa cells transfected with pCHA-puro empty vector (lane 739 
1), pCHA-DEK (Lane 2), or pCHA-puro-USF1 (lane 3) at 24 hpt, and subjected to 10% 740 
SDS-PAGE, followed by western blot analyses using anti-HA (upper panel) and 741 
anti-β-actin (lower panel) antibodies.  (C)  Localization of HA-DEK and HA-USF1.  742 
HeLa cells were transfected pCHA-puro empty vector, pCHA-DEK, or 743 
 36
pCHA-puro-USF1.  At 24 hpt, cells were mock-infected or infected with HAdV5 at an 744 
MOI of 50, and at 18 hpi subjected to IF assays using anti-HA and anti-DBP antibodies.   745 
 746 
FIG. 6.  Role of DBP oligomerization on histone localization.  (A)  Schematic 747 
diagrams of full-length DBP and C-terminally deleted mutant DBPΔC.  DBP of 748 
HAdV5 consists of 529 aa, and the C-terminal 17 aa (513-529) functions as an “arm” 749 
for oligomerization.  DBPΔC lacks the C-terminal 17 aa.  (B)  Western blot analyses.  750 
HeLa cells stably expressing histone H3.3-EGFP were transfected with pCHA-puro 751 
empty vector (lane 1), pCHA-puro-DBP (lane 2), or pCHA-puro-DBPΔC (lane 3), and 752 
lysates prepared at 36 hpt were subjected to 10% SDS-PAGE, followed by western blot 753 
analyses using anti-HA (top), anti-DBP (middle), and anti-β-actin (bottom panel) 754 
antibodies.  (C)  IF analyses.  At 36 hpt, cells as described in (B) grown on cover 755 
slips were subjected to IF analyses using anti-HA (left panels) and anti-DBP (right 756 
panels) antibodies as described above.  Higher-magnified images of the regions 757 
marked by squares are shown below.   758 
 759 
FIG. 7.  A hypothetical model for viral chromatin structure during infection cycle.  760 
For detail, see Discussion section.   761 
 762 







